What is Avalo Therapeutics, Inc. Common Stock's Market Cap?

Avalo Therapeutics, Inc. Common Stock's Market Cap is $1.0B, based on as-reported figures from SEC (XBRL) filings.

What is Avalo Therapeutics, Inc. Common Stock's Enterprise Value?

Avalo Therapeutics, Inc. Common Stock's Enterprise Value is $610.4M, based on as-reported figures from SEC (XBRL) filings.

What is Avalo Therapeutics, Inc. Common Stock's Price / Sales?

Avalo Therapeutics, Inc. Common Stock's Price / Sales is 17129.8×, based on as-reported figures from SEC (XBRL) filings.

What is Avalo Therapeutics, Inc. Common Stock's EV / Revenue?

Avalo Therapeutics, Inc. Common Stock's EV / Revenue is 10345.4×, based on as-reported figures from SEC (XBRL) filings.

What is Avalo Therapeutics, Inc. Common Stock's EV / EBITDA?

Avalo Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Avalo Therapeutics, Inc. Common Stock's Revenue (TTM)?

Avalo Therapeutics, Inc. Common Stock's Revenue (TTM) is $59.0K, based on as-reported figures from SEC (XBRL) filings.

What is Avalo Therapeutics, Inc. Common Stock's Net Income (TTM)?

Avalo Therapeutics, Inc. Common Stock's Net Income (TTM) is -$100.3M, based on as-reported figures from SEC (XBRL) filings.

What is Avalo Therapeutics, Inc. Common Stock's EBITDA?

Avalo Therapeutics, Inc. Common Stock's EBITDA is -$91.3M, based on as-reported figures from SEC (XBRL) filings.

What is Avalo Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?

Avalo Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -1.87, based on as-reported figures from SEC (XBRL) filings.

What is Avalo Therapeutics, Inc. Common Stock's EBITDA Margin?

Avalo Therapeutics, Inc. Common Stock's EBITDA Margin is -154662.7%, based on as-reported figures from SEC (XBRL) filings.

Avalo Therapeutics, Inc. Common Stock (AVTX) Financial Statements

Avalo Therapeutics, Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG001V1GPQ9

XNAS · usd

18.85▼ 0.87 (-4.39%)

As of 2026-09-09

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales

EV / Revenue

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin

Net Debt

Trading Information

Previous Close19.71

Day's Range18.95 – 20.49

52-Week Range9.54 – 24.27

Volume779.3K

Avg Volume755.3K

Share Statistics

Shares Outstanding

Employees33

ExchangeXNAS

Listed2015-11-13

Share count as of August 3, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Avalo Therapeutics, Inc. Common Stock (AVTX)

What is Avalo Therapeutics, Inc. Common Stock's Market Cap?: Avalo Therapeutics, Inc. Common Stock's Market Cap is $1.0B, based on as-reported figures from SEC (XBRL) filings.
What is Avalo Therapeutics, Inc. Common Stock's Enterprise Value?: Avalo Therapeutics, Inc. Common Stock's Enterprise Value is $610.4M, based on as-reported figures from SEC (XBRL) filings.
What is Avalo Therapeutics, Inc. Common Stock's Price / Sales?: Avalo Therapeutics, Inc. Common Stock's Price / Sales is 17129.8×, based on as-reported figures from SEC (XBRL) filings.
What is Avalo Therapeutics, Inc. Common Stock's EV / Revenue?: Avalo Therapeutics, Inc. Common Stock's EV / Revenue is 10345.4×, based on as-reported figures from SEC (XBRL) filings.
What is Avalo Therapeutics, Inc. Common Stock's EV / EBITDA?: Avalo Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Avalo Therapeutics, Inc. Common Stock's Revenue (TTM)?: Avalo Therapeutics, Inc. Common Stock's Revenue (TTM) is $59.0K, based on as-reported figures from SEC (XBRL) filings.
What is Avalo Therapeutics, Inc. Common Stock's Net Income (TTM)?: Avalo Therapeutics, Inc. Common Stock's Net Income (TTM) is -$100.3M, based on as-reported figures from SEC (XBRL) filings.
What is Avalo Therapeutics, Inc. Common Stock's EBITDA?: Avalo Therapeutics, Inc. Common Stock's EBITDA is -$91.3M, based on as-reported figures from SEC (XBRL) filings.
What is Avalo Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?: Avalo Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -1.87, based on as-reported figures from SEC (XBRL) filings.
What is Avalo Therapeutics, Inc. Common Stock's EBITDA Margin?: Avalo Therapeutics, Inc. Common Stock's EBITDA Margin is -154662.7%, based on as-reported figures from SEC (XBRL) filings.